- Home
- TCBS vs DXR Comparison
TCBS vs DXR Comparison
Compare TCBS & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBS | DXR |
|---|---|---|
| Founded | 1934 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 59.0M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TCBS | DXR |
|---|---|---|
| Price | $17.64 | $10.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.0K | ★ 1.6K |
| Earning Date | 04-24-2026 | 02-27-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 327.27 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ $26.56 | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.72 | $8.56 |
| 52 Week High | $20.00 | $14.76 |
Technical Indicators
Market Signals| Indicator | TCBS | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | N/A |
| Support Level | $17.23 | N/A |
| Resistance Level | $17.93 | N/A |
| Average True Range (ATR) | 0.12 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 38.81 | 0.00 |
Price Performance
Historical ComparisonAbout TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.